United States · FDA National Drug Code directory
Cisatracurium Besylate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0143-9396_6c1a13e7-546c-4b06-8217-73f2c4b7ed57
- Product NDC
- 0143-9396
- Form
- INJECTION
- Composition / generic term
- Cisatracurium Besylate
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230531
- Source listing expiry
- 20261231
Source-listed ingredients
- CISATRACURIUM BESYLATE — 2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (0143-9396-01) / 5 mL in 1 VIAL · 0143-9396-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →